Loading...
MariMed Inc.
MRMD.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.14
CA$0.05(52.63%)
MariMed Inc. (MRMD.CN) Financial Performance & Statements
Review MariMed Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
6.30%
↑ 6.30%
Operating Income Growth
-80.69%
↓ 80.69%
Net Income Growth
24.12%
↑ 24.12%
Operating Cash Flow Growth
-14.22%
↓ 14.22%
Operating Margin
0.03%
↑ 0.03%
Gross Margin
38.95%
↑ 38.95%
Net Profit Margin
-10.33%
↓ 10.33%
ROE
-24.86%
↓ 24.86%
ROIC
0.03%
↑ 0.03%
MariMed Inc. (MRMD.CN) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for MariMed Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $39.002M | $40.59M | $40.44M | $37.93M |
| Cost of Revenue | $26.29M | $23.81M | $30.49M | $27.93M |
| Gross Profit | $12.71M | $16.78M | $9.95M | $10.007M |
| Gross Profit Ratio | $0.33 | $0.41 | $0.25 | $0.26 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $7.79M | $7.93M | $8.64M | $7.90M |
| Operating Expenses | $14.11M | $15.44M | $8.64M | $7.90M |
| Total Costs & Expenses | $40.41M | $39.25M | $39.13M | $35.83M |
| Interest Income | $38000.00 | $25000.00 | $25000.00 | $26000.00 |
| Interest Expense | $1.89M | $1.71M | $1.72M | $1.63M |
| Depreciation & Amortization | $3.04M | $2.69M | $2.82M | $2.31M |
| EBITDA | $1.68M | $4.05M | $4.12M | $4.42M |
| EBITDA Ratio | $0.04 | $0.10 | $0.10 | $0.12 |
| Operating Income | -$1.41M | $1.34M | $1.31M | $2.10M |
| Operating Income Ratio | -$0.04 | $0.03 | $0.03 | $0.06 |
| Other Income/Expenses (Net) | -$1.85M | -$1.68M | -$1.73M | -$1.62M |
| Income Before Tax | -$3.25M | -$340000.00 | -$773000.00 | $398000.00 |
| Income Before Tax Ratio | -$0.08 | -$0.008 | -$0.02 | $0.01 |
| Income Tax Expense | $4.95M | $655000.00 | $866000.00 | $1.69M |
| Net Income | -$8.20M | -$1.01M | -$1.65M | -$1.30M |
| Net Income Ratio | -$0.21 | -$0.02 | -$0.04 | -$0.03 |
| EPS | -$0.02 | -$0.003 | -$0.004 | -$0.004 |
| Diluted EPS | -$0.02 | -$0.003 | -$0.004 | -$0.004 |
| Weighted Avg Shares Outstanding | $381.25M | $380.60M | $379.51M | $375.21M |
| Weighted Avg Shares Outstanding (Diluted) | $381.25M | $380.60M | $379.51M | $375.21M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan